...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication

Wouldn't that be a matter of looking back at the PI and PII trial at the dose response results. Whether they have the depth of detail on those trials as they do on the most recent trials would also be a limiting factor.

Heck is Cocco the monkey still alive from the last animal trial before PI started?

tada

Share
New Message
Please login to post a reply